SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?


To: Dave who wrote (221)1/22/2001 10:55:46 PM
From: Jim Oravetz  Read Replies (2) | Respond to of 370
 
In three years time, it will be almost certain that the products that are in Phase I testing will either be failures or approved. If the science behind the company is solid, then money should not be a concern in three years time. If it looks like approval is more certain, getting beyond PII, then issueing more stock to raise cash levels is the most likely option.

Jim